A citation-based method for searching scientific literature

Allen Wang, Jennifer B Green, Jonathan L Halperin, Jonathan P Piccini. J Am Coll Cardiol 2019
Times Cited: 108







List of co-cited articles
959 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
Justin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, Bernard J Gersh, Peter R Kowey, Kenneth W Mahaffey, Daniel E Singer, Elaine M Hylek, Alan S Go, Eric D Peterson,[...]. J Am Coll Cardiol 2017
75
40

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
Thomas A Zelniker, Marc P Bonaca, Remo H M Furtado, Ofri Mosenzon, Julia F Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding,[...]. Circulation 2020
120
24

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.
Rachel R Huxley, Kristian B Filion, Suma Konety, Alvaro Alonso. Am J Cardiol 2011
306
20


Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.
Anna Plitt, Darren K McGuire, Robert P Giugliano. JAMA Cardiol 2017
45
35

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks,[...]. Eur Heart J 2016
16

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.
Christos A Goudis, Panagiotis Korantzopoulos, Ioannis V Ntalas, Eleftherios M Kallergis, Tong Liu, Dimitrios G Ketikoglou. Int J Cardiol 2015
75
20



Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
14

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
13


Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
13

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
Giuseppe Patti, Markus Lucerna, Ilaria Cavallari, Elisabetta Ricottini, Giulia Renda, Ladislav Pecen, Fabio Romeo, Jean-Yves Le Heuzey, Josè Luis Zamorano, Paulus Kirchhof,[...]. J Am Coll Cardiol 2017
55
21

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.
Shang-Hung Chang, Lung-Sheng Wu, Meng-Jiun Chiou, Jia-Rou Liu, Kuang-Hui Yu, Chang-Fu Kuo, Ming-Shien Wen, Wei-Jan Chen, Yung-Hsin Yeh, Lai-Chu See. Cardiovasc Diabetol 2014
111
12


Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
Mia Vicki Fangel, Peter Brønnum Nielsen, Jette Kolding Kristensen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Y H Lip, Martin Bach Jensen. Circ Arrhythm Electrophysiol 2019
33
30


Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).
Rajeev K Pathak, Melissa E Middeldorp, Megan Meredith, Abhinav B Mehta, Rajiv Mahajan, Christopher X Wong, Darragh Twomey, Adrian D Elliott, Jonathan M Kalman, Walter P Abhayaratna,[...]. J Am Coll Cardiol 2015
518
10

Diabetes mellitus, glycemic control, and risk of atrial fibrillation.
Sascha Dublin, Nicole L Glazer, Nicholas L Smith, Bruce M Psaty, Thomas Lumley, Kerri L Wiggins, Richard L Page, Susan R Heckbert. J Gen Intern Med 2010
170
10

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
10

SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
Wen-Jie Li, Xing-Qing Chen, Ling-Ling Xu, Yuan-Qing Li, Bi-Hui Luo. Cardiovasc Diabetol 2020
40
25

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, Demetrios Tsachris, Timothy Morgan, Jan Basile, Thomas Bigger, William Cushman, David Goff, Elsayed Z Soliman,[...]. Am J Cardiol 2014
95
9

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
9

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
9

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
Sumeet S Chugh, Rasmus Havmoeller, Kumar Narayanan, David Singh, Michiel Rienstra, Emelia J Benjamin, Richard F Gillum, Young-Hoon Kim, John H McAnulty, Zhi-Jie Zheng,[...]. Circulation 2014
9

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
Michela Brambatti, Harald Darius, Jonas Oldgren, Andreas Clemens, Herbert H Noack, Martina Brueckmann, Salim Yusuf, Lars Wallentin, Michael D Ezekowitz, Stuart J Connolly,[...]. Int J Cardiol 2015
55
16

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, Anne S Hellkamp, Yuliya Lokhnygina, Manesh R Patel, Richard C Becker, Günter Breithardt, Werner Hacke, Graeme J Hankey,[...]. Am Heart J 2015
81
11

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
E J Benjamin, D Levy, S M Vaziri, R B D'Agostino, A J Belanger, P A Wolf. JAMA 1994
9

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study.
Rachel R Huxley, Faye L Lopez, Aaron R Folsom, Sunil K Agarwal, Laura R Loehr, Elsayed Z Soliman, Rich Maclehose, Suma Konety, Alvaro Alonso. Circulation 2011
387
9

Modifiable Risk Factors and Atrial Fibrillation.
Dennis H Lau, Stanley Nattel, Jonathan M Kalman, Prashanthan Sanders. Circulation 2017
299
9

Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
Stefano Fumagalli, Salah A Said, Cecile Laroche, Debbie Gabbai, Serena Boni, Niccolò Marchionni, Giuseppe Boriani, Aldo P Maggioni, Agata Musialik-Lydka, Adam Sokal,[...]. Eur Heart J Cardiovasc Pharmacother 2018
25
36

Atrial fibrillation and its arrhythmogenesis associated with insulin resistance.
Yi-Hsin Chan, Gwo-Jyh Chang, Ying-Ju Lai, Wei-Jan Chen, Shang-Hung Chang, Li-Man Hung, Chi-Tai Kuo, Yung-Hsin Yeh. Cardiovasc Diabetol 2019
37
24

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.
Loryn J Bohne, Dustin Johnson, Robert A Rose, Stephen B Wilton, Anne M Gillis. Front Physiol 2019
42
21

Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.
Shilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic, Annika Rosengren, Marcus Lind. Cardiovasc Diabetol 2020
32
28

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial.
Justin A Ezekowitz, Basil S Lewis, Renato D Lopes, Daniel M Wojdyla, John J V McMurray, Michael Hanna, Dan Atar, M Cecilia Bahit, Matyas Keltai, Jose L Lopez-Sendon,[...]. Eur Heart J Cardiovasc Pharmacother 2015
46
17


Association Between Pre-Ablation Glycemic Control and Outcomes Among Patients With Diabetes Undergoing Atrial Fibrillation Ablation.
Eoin Donnellan, Philip Aagaard, Mohamed Kanj, Wael Jaber, Mohamed Elshazly, Michael Hoosien, Bryan Baranowski, Ayman Hussein, Walid Saliba, Oussama Wazni. JACC Clin Electrophysiol 2019
31
25


Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study.
Rachel R Huxley, Alvaro Alonso, Faye L Lopez, Kristian B Filion, Sunil K Agarwal, Laura R Loehr, Elsayed Z Soliman, James S Pankow, Elizabeth Selvin. Heart 2012
137
8


Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.
Dagfinn Aune, Tingting Feng, Sabrina Schlesinger, Imre Janszky, Teresa Norat, Elio Riboli. J Diabetes Complications 2018
57
14

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Xin Du, Toshiharu Ninomiya, Bastiaan de Galan, Edward Abadir, John Chalmers, Avinesh Pillai, Mark Woodward, Mark Cooper, Stephen Harrap, Pavel Hamet,[...]. Eur Heart J 2009
146
8

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial.
Michael Böhm, Jonathan Slawik, Martina Brueckmann, Michaela Mattheus, Jyothis T George, Anne Pernille Ofstad, Silvio E Inzucchi, David Fitchett, Stefan D Anker, Nikolaus Marx,[...]. Eur J Heart Fail 2020
38
21


Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.
Shotaro Saito, Yasushi Teshima, Akira Fukui, Hidekazu Kondo, Satoru Nishio, Mikiko Nakagawa, Tetsunori Saikawa, Naohiko Takahashi. Cardiovasc Res 2014
73
9

Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, Sabina A Murphy, Stephen D Wiviott, Jonathan L Halperin, Albert L Waldo, Michael D Ezekowitz, Jeffrey I Weitz, Jindřich Špinar,[...]. N Engl J Med 2013
7

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
Hany S Abed, Gary A Wittert, Darryl P Leong, Masoumeh G Shirazi, Bobak Bahrami, Melissa E Middeldorp, Michelle F Lorimer, Dennis H Lau, Nicholas A Antic, Anthony G Brooks,[...]. JAMA 2013
431
7

Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study.
Jannik L Pallisgaard, Anne-Marie Schjerning, Tommi B Lindhardt, Kristina Procida, Morten L Hansen, Christian Torp-Pedersen, Gunnar H Gislason. Eur J Prev Cardiol 2016
68
10

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
Ben Freedman, John Camm, Hugh Calkins, Jeffrey S Healey, Mårten Rosenqvist, Jiguang Wang, Christine M Albert, Craig S Anderson, Sotiris Antoniou, Emelia J Benjamin,[...]. Circulation 2017
332
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.